APA (7th ed.) Citation

I, D., E, C., G, A., M, V., JI, K., & B, N. (2024). Successful treatment of MAP2K1 mutant stage IV-M1d melanoma with trametinib plus low-dose dabrafenib: A case report. Frontiers in medicine, 11, 1436774. https://doi.org/10.3389/fmed.2024.1436774

Chicago Style (17th ed.) Citation

I, Dirven, Calliauw E, Awada G, Vounckx M, Kessels JI, and Neyns B. "Successful Treatment of MAP2K1 Mutant Stage IV-M1d Melanoma with Trametinib Plus Low-dose Dabrafenib: A Case Report." Frontiers in Medicine 11 (2024): 1436774. https://doi.org/10.3389/fmed.2024.1436774.

MLA (9th ed.) Citation

I, Dirven, et al. "Successful Treatment of MAP2K1 Mutant Stage IV-M1d Melanoma with Trametinib Plus Low-dose Dabrafenib: A Case Report." Frontiers in Medicine, vol. 11, 2024, p. 1436774, https://doi.org/10.3389/fmed.2024.1436774.